Peter Hollander

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Ingår i Biomolecules, 2023

• DOI för Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Ladda ner fulltext (pdf) av Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Hellbacher, Erik; Sundström, Christer; Molin, Daniel; Baecklund, Eva et al.

Ingår i Cancers, 2022

• DOI för Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity
• Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

Paulsen, Karin; Marincevic, Millaray; Cavelier, Lucia; Hollander, Peter et al.

Ingår i Diagnostics, 2022

• DOI för LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients
• Ladda ner fulltext (pdf) av LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Ingår i Acta Oncologica, s. 824-829, 2022

• DOI för Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Checkpoint CD47 expression in classical Hodgkin lymphoma

Gholiha, Alex Reza; Hollander, Peter; Löf, Liza; Glimelius, Ingrid et al.

Ingår i British Journal of Haematology, s. 580-589, 2022

• DOI för Checkpoint CD47 expression in classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Checkpoint CD47 expression in classical Hodgkin lymphoma

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Gholiha, Alex R.; Hollander, Peter; Löf, Liza; Larsson, Anders et al.

Ingår i Cancers, 2022

• DOI för Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue
• Ladda ner fulltext (pdf) av Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Sundström, Christer; Hollander, Peter

Ingår i Immunobiology, 2021

• DOI för Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies
• Ladda ner fulltext (pdf) av Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

Rodrigues, Joana M.; Nikkarinen, Anna; Hollander, Peter; Weibull, Caroline E. et al.

Ingår i British Journal of Haematology, s. 520-531, 2021

• DOI för Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
• Ladda ner fulltext (pdf) av Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Ingår i Acta Oncologica, s. 531-538, 2021

• DOI för PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Ladda ner fulltext (pdf) av PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Sima, Andreea; Hollander, Peter; Baecklund, Eva; Smedby, Karin E. et al.

Ingår i British Journal of Haematology, s. 568-579, 2021

• DOI för Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
• Ladda ner fulltext (pdf) av Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Gholiha, Alex R.; Hollander, Peter; Glimelius, Ingrid; Hedström, Gustaf et al.

Ingår i Blood Advances, s. 1671-1681, 2021

• DOI för Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Ingår i American Journal of Hematology, 2020

• DOI för Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Hollander, Peter; Ginman, Beatrice; Molin, Daniel; Enblad, Gunilla et al.

Ingår i Immunobiology, 2020

• DOI för Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Abdulla, Maysaa; Guglielmo, Priscilla; Hollander, Peter; Åström, Gunnar et al.

Ingår i European Journal of Haematology, s. 207-213, 2020

• DOI för Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

de Matos Rodrigues, Joana; Lokhande, Lavanya; Olsson, Lina M.; Hassan, May et al.

Ingår i Blood Advances, s. 4370-4385, 2024

• DOI för CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
• Ladda ner fulltext (pdf) av CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

Rodrigues, Joana M.; Hollander, Peter; Schmidt, Lina; Gkika, Eirinaios et al.

Ingår i Haematologica, s. 1171-1183, 2024

• DOI för MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study
• Ladda ner fulltext (pdf) av MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Nikkarinen, Anna; Lokhande, Lavanya; Amini, Rose-Marie; Jerkeman, Mats et al.

Ingår i Blood Advances, s. 5304-5313, 2023

• DOI för Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Ingår i Biomolecules, 2023

• DOI för Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Ladda ner fulltext (pdf) av Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Hellbacher, Erik; Sundström, Christer; Molin, Daniel; Baecklund, Eva et al.

Ingår i Cancers, 2022

• DOI för Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity
• Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

de Matos Rodrigues, Joana; Lokhande, Lavanya; Olsson, Lina M.; Hassan, May et al.

Ingår i Blood Advances, s. 4370-4385, 2024

• DOI för CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
• Ladda ner fulltext (pdf) av CD163⁺ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

Rodrigues, Joana M.; Hollander, Peter; Schmidt, Lina; Gkika, Eirinaios et al.

Ingår i Haematologica, s. 1171-1183, 2024

• DOI för MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study
• Ladda ner fulltext (pdf) av MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53: a Nordic Lymphoma Group study

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Nikkarinen, Anna; Lokhande, Lavanya; Amini, Rose-Marie; Jerkeman, Mats et al.

Ingår i Blood Advances, s. 5304-5313, 2023

• DOI för Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Ingår i Biomolecules, 2023

• DOI för Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Ladda ner fulltext (pdf) av Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

Hellbacher, Erik; Sundström, Christer; Molin, Daniel; Baecklund, Eva et al.

Ingår i Cancers, 2022

• DOI för Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity
• Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

Paulsen, Karin; Marincevic, Millaray; Cavelier, Lucia; Hollander, Peter et al.

Ingår i Diagnostics, 2022

• DOI för LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients
• Ladda ner fulltext (pdf) av LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Ingår i Acta Oncologica, s. 824-829, 2022

• DOI för Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Checkpoint CD47 expression in classical Hodgkin lymphoma

Gholiha, Alex Reza; Hollander, Peter; Löf, Liza; Glimelius, Ingrid et al.

Ingår i British Journal of Haematology, s. 580-589, 2022

• DOI för Checkpoint CD47 expression in classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Checkpoint CD47 expression in classical Hodgkin lymphoma

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Gholiha, Alex R.; Hollander, Peter; Löf, Liza; Larsson, Anders et al.

Ingår i Cancers, 2022

• DOI för Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue
• Ladda ner fulltext (pdf) av Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Sundström, Christer; Hollander, Peter

Ingår i Immunobiology, 2021

• DOI för Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies
• Ladda ner fulltext (pdf) av Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies

Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

Rodrigues, Joana M.; Nikkarinen, Anna; Hollander, Peter; Weibull, Caroline E. et al.

Ingår i British Journal of Haematology, s. 520-531, 2021

• DOI för Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
• Ladda ner fulltext (pdf) av Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Ingår i Acta Oncologica, s. 531-538, 2021

• DOI för PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Ladda ner fulltext (pdf) av PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Sima, Andreea; Hollander, Peter; Baecklund, Eva; Smedby, Karin E. et al.

Ingår i British Journal of Haematology, s. 568-579, 2021

• DOI för Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
• Ladda ner fulltext (pdf) av Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Gholiha, Alex R.; Hollander, Peter; Glimelius, Ingrid; Hedström, Gustaf et al.

Ingår i Blood Advances, s. 1671-1681, 2021

• DOI för Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Abdulla, Maysaa; Hollander, Peter; Pandzic, Tatjana; Mansouri, Larry et al.

Ingår i American Journal of Hematology, s. 57-67, 2020

• DOI för Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

CD30 expression and survival in posttransplant lymphoproliferative disorders

Kinch, Amelie; Amini, Rose-Marie; Hollander, Peter; Molin, Daniel et al.

Ingår i Acta Oncologica, s. 673-680, 2020

• DOI för CD30 expression and survival in posttransplant lymphoproliferative disorders
• Ladda ner fulltext (pdf) av CD30 expression and survival in posttransplant lymphoproliferative disorders

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Ingår i American Journal of Hematology, 2020

• DOI för Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Hollander, Peter; Ginman, Beatrice; Molin, Daniel; Enblad, Gunilla et al.

Ingår i Immunobiology, 2020

• DOI för Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Abdulla, Maysaa; Guglielmo, Priscilla; Hollander, Peter; Åström, Gunnar et al.

Ingår i European Journal of Haematology, s. 207-213, 2020

• DOI för Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Gholiha, Alex R.; Hollander, Peter; Hedström, Gustaf; Sundström, Christer et al.

Ingår i British Journal of Haematology, s. 192-201, 2019

• DOI för High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Amini, Rose-Marie; Enblad, Gunilla; Hollander, Peter; Laszlo, S. et al.

Ingår i BMC Cancer, 2019

• DOI för Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
• Ladda ner fulltext (pdf) av Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Hollander, Peter; Amini, Rose-Marie; Ginman, Beatrice; Molin, Daniel et al.

Ingår i PLOS ONE, 2018

• DOI för Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Hollander, Peter; Rostgaard, Klaus; Ekström-Smedby, Karin; Molin, Daniel et al.

Ingår i European Journal of Haematology, s. 88-97, 2018

• DOI för An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Hollander, Peter; Kamper, Peter; Smedby, Karin Ekstrom; Enblad, Gunilla et al.

Ingår i Blood Advances, s. 1427-1439, 2017

• DOI för High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

High Expression Of Programmed Cell Death Receptor 1 In The Tumor Microenvironment Is Associated With Inferior Event Free Survival In Classical Hodgkin Lymphoma

Hollander, Peter; Kamper, P.; Smedby, K. E.; Enblad, Gunilla et al.

Ingår i Haematologica, s. 1-2, 2016

Prognostic Implications Of An Active, Innate Or Anergic Immune Response In The Hodgkin Lymphoma Tumor Microenvironment

Hollander, Peter; Rostgaard, K.; Smedby, K. E.; Molin, Daniel et al.

Ingår i Haematologica, s. 3-3, 2016

Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Hollander, Peter; Rostgaard, Klaus; Smedby, Karin E.; Chang, Ellen T. et al.

Ingår i American Journal of Epidemiology, s. 624-632, 2015

• DOI för Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Epidemiology and prognosis in classical Hodgkin lymphoma

Hollander, Peter

2018

• Ladda ner fulltext (pdf) av Epidemiology and prognosis in classical Hodgkin lymphoma

PD-1 and PD-L1 are upregulated in paired consecutive biopsies with classical Hodgkin lymphoma

Hollander, Peter; Amini, Rose-Marie; Ginman, Beatrice; Enblad, Gunilla et al.